Literature DB >> 19398170

Prevention of orthogonal array of particles formation as a treatment approach for neuromyelitis optica.

Arne Warth1.   

Abstract

Neuromyelitis optica (NMO) is an uncommon, life-threatening demyelinating disease that produces transverse myelitis and optic neuritis. An important pathogenetic mechanism belongs to NMO-IgG autoantibodies directed against the ultrastructure of the water channel aquaporin-4 (AQP4), the so-called orthogonal arrays of particles (OAPs). With respect to the yet known data about OAP formation it is suggested to modulate the AQP4-M23 isoform to prevent the aggregation of AQP4 tetramers into higher organized structures. Without specific target for the NMO-IgGs the inflammation and thus the resulting demyelination may be stopped without the need for immunosuppressive agents with severe side-effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398170     DOI: 10.1016/j.mehy.2009.02.036

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 2.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

3.  Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.

Authors:  Romain Marignier; Pascale Giraudon; Sandra Vukusic; Christian Confavreux; Jérôme Honnorat
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.